Investigation Overview
July 03, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN), was announced concerning whether the takeover of SciClone Pharmaceuticals, Inc. for $11.18 per share is unfair to NASDAQ:SCLN stockholders. The investigation by a law firm concerns whether certain officers and directors of SciCl...
You must register (for free) or login to view the entire investigation.